article thumbnail

Data is Knowledge with Otha Smith III

The Cannigma

The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry. Okay, we got to prove it. 0:14:10.3]

Data 52
article thumbnail

Finding ‘Releaf’: Put Data in Your Pipe and Smoke It

The Cannigma

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf.

Data 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Press Release: Psychedelic Invest Launches New Podcast; Announces More Episodic Content in Pipeline

Cannabis Law Report

FORT LAUDERDALE, Fla. , April 28, 2022 /PRNewswire/ — Psychedelic Invest ( PsychedelicInvest.com ), an online resource educating stakeholders about the burgeoning psychedelic medicine industry, is pleased to announce the launch of the Psychedelic Invest Podcast. Hadas Alterman : Founding Partner at Plant Medicine Law Group.

Data 59
article thumbnail

NORML Publish Book Summarizing Hundreds of Studies Assessing the Safety and Efficacy of Cannabis for Patients ….Now Available on Kindle

Cannabis Law Report

NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.

Safety 52
article thumbnail

Introducing AJEM- The American Jnl Of Endocannabinoid Medicine – Read Issue 1 For FREE

Cannabis Law Report

Editor’s note: The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data. On the one hand, cannabinoids produced by cannabis clearly have medicinal benefits.3-5

article thumbnail

Press Release: Ixtlan Bioscience Announces the Filing of New Patent for the Psilocybin Treatment of Alzheimer’s Disease and Brain Pathologies

Cannabis Law Report

providing the extensive data that will be used to further improve the product. Ixtlan Bioscience is an Israeli based biotech company devoted to defining and utilizing psilocybin micro-dosing to advance safe and accessible psilocybin medicine to slow down the progression of Alzheimer’s and dementia diseases.

article thumbnail

Cannabis Seeds Market To Observe Highest CAGR Growth of 18.70 by 2029 | Market Analysed by Growth, Trends, Share, Industry Size and Key Player Analysis

Cannabis Law Report

NEW YORK , July 19, 2022 /PRNewswire/ — Data Bridge Market research has recently released expansive research titled “ Global Cannabis Seeds Market ” guarantees you will remain better informed than your competition. According to Data Bridge Market Research, Global Cannabis Seeds Market was valued at USD 1,445.05